These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21368431)

  • 41. [Large-scale production of recombinant adeno-associated virus (rAAV)].
    Wang F; Diao Y; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1608-13. PubMed ID: 20222456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant adeno-associated viral vector reference standards.
    Moullier P; Snyder RO
    Methods Enzymol; 2012; 507():297-311. PubMed ID: 22365780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
    Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
    Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Construction and expression of recombinant adeno-associated virus vector containing HSV1-TK gene].
    Ding ZX; Tan Q; Liu SZ; Liu D; Li ZQ; Peng JQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):210-5. PubMed ID: 18382054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization.
    Sun L; Li J; Xiao X
    Nat Med; 2000 May; 6(5):599-602. PubMed ID: 10802720
    [No Abstract]   [Full Text] [Related]  

  • 48. Production and characterization of adeno-associated viral vectors.
    Grieger JC; Choi VW; Samulski RJ
    Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Ant-Shepherdin[79-87]].
    Tang XJ; Ping BH; Pan CE; Yang GX; Wang QY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1143-6. PubMed ID: 19068195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.
    Bera A; Sen D
    Heart Fail Rev; 2017 Nov; 22(6):795-823. PubMed ID: 28589503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adeno-associated virus vectors.
    Carter BJ
    Curr Opin Biotechnol; 1992 Oct; 3(5):533-9. PubMed ID: 1369403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation.
    Duan D; Yue Y; Yan Z; Engelhardt JF
    Nat Med; 2000 May; 6(5):595-8. PubMed ID: 10802719
    [No Abstract]   [Full Text] [Related]  

  • 53. Adeno-associated virus-mediated gene therapy in cardiovascular disease.
    Hammoudi N; Ishikawa K; Hajjar RJ
    Curr Opin Cardiol; 2015 May; 30(3):228-34. PubMed ID: 25783685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drawing sticky adeno-associated viruses on surfaces for spatially patterned gene expression.
    Kim E; Song IT; Lee S; Kim JS; Lee H; Jang JH
    Angew Chem Int Ed Engl; 2012 Jun; 51(23):5598-601. PubMed ID: 22539413
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent Advancements in Cardiovascular Gene Therapy and Vascular Biology.
    Laakkonen JP; Ylä-Herttuala S
    Hum Gene Ther; 2015 Aug; 26(8):518-24. PubMed ID: 26192706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene therapy for cardiovascular disease.
    Kozarsky KF
    Curr Opin Pharmacol; 2001 Apr; 1(2):197-202. PubMed ID: 11714096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death.
    Okada T; Shimazaki K; Nomoto T; Matsushita T; Mizukami H; Urabe M; Hanazono Y; Kume A; Tobita K; Ozawa K; Kawai N
    Methods Enzymol; 2002; 346():378-93. PubMed ID: 11883081
    [No Abstract]   [Full Text] [Related]  

  • 58. Safety of Adeno-associated virus-based vector-mediated gene therapy-impact of vector dose.
    Maurya S; Sarangi P; Jayandharan GR
    Cancer Gene Ther; 2022 Oct; 29(10):1305-1306. PubMed ID: 35027711
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombinant Adeno-Associated Virus-Based Gene Therapy for Disorders Detected by Newborn Screening: Inherent Limitations of This Approach.
    Flotte TR
    Hum Gene Ther; 2018 Apr; 29(4):401-402. PubMed ID: 29668376
    [No Abstract]   [Full Text] [Related]  

  • 60. Adeno-associated virus type 2 vector for transduction of hematopoietic cells.
    Ogniben E; Haas R
    Recent Results Cancer Res; 1998; 144():86-92. PubMed ID: 9304711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.